Clinical Trials Browser

Phase 2 × Breast Neoplasms × Granulocyte Colony-Stimulating Factor × Clear all

Breast Neoplasms

NCT05520723 2025-12-04

PRIMED

Phase 2 Completed

50 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00513695 2019-08-07

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Phase 2 Completed

68 enrolled 10 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00194779 2018-03-12

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

Phase 2 Completed

50 enrolled 13 charts

Breast

Breast Neoplasms

NCT00407888 2017-08-31

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

Phase 2 Completed

60 enrolled 11 charts

Breast

Breast Neoplasms

NCT00119262 2014-05-15

Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

Phase 2 Completed

226 enrolled 8 charts

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00049114 2013-06-06

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

Phase 2 Completed

62 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00007904 2012-10-02

Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

Phase 2 Completed

16 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00005800 2012-09-25

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Phase 2 Completed

45 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00194753 2012-09-13

Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12

Phase 2 Completed

80 enrolled

Breast

Breast Neoplasms

NCT00194740 2007-12-06

Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer

Phase 2 Completed

48 enrolled

Breast

Breast Neoplasms

Clinical Trials

SATROPIN

PRIMED

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery

Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer

Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer

Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G-CSF for 12 Wks; Wkly Taxol x 12

Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer